One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
Affiliate of Sage Healthcare Partners purchases bankrupt Michigan CCRC for $76.3M
By
Amy Novotney
May 10, 2021
Dearborn, MI-based continuing care retirement community Henry Ford Village announced late Thursday that it had received a successful bid from HFV OPCO LLC, a newly formed affiliate of Sage Healthcare Partners...
Fourth mRNA COVID-19 vaccine immunogenic, safe
Mar 24, 2022
Vaccine efficacy 30% for BNT162b2(Pfizer) and 11 percent for mRNA-1273 (Moderna) against any SARS-CoV-2 infection.
Allergy history may up risk for reactions to mRNA COVID-19 vaccine
Nov 04, 2021
The risk for allergic reactions within three days of vaccination is higher for those with history of high-risk allergy, but most completed the two-dose regimen. The mRNA vaccines approved for use against...
Ad26.COV2.S, mRNA boosters immunogenic after Ad26.COV2.S
Jan 24, 2022
Compared with a homologous booster, a heterologous booster with an mRNA-based vaccine yielded a larger increase in binding antibodies.
SARS-CoV-2 vaccines effectively prevent infection in VA population
Jul 20, 2021
Vaccine effectiveness was 96.2% for Pfizer-BioNTech BNT162b2 and 98.2% for Moderna mRNA-1273.
Peer-to-Peer: How ConcertoCare has tapped technology, analytics and PACE to upend home healthcare
By
Diane Eastabrook
May 17, 2021
In January, ConcertoCare a tech-enabled, risk-based home healthcare provider, named Julian Harris, M.D., to lead the company into a post-COVID-19 landscape.
Veterans report low rates of adverse events with mRNA vaccines
Jun 16, 2022
Rates were slightly higher at 42 days for those receiving the Pfizer versus Moderna vaccine.
Antibody response prolonged with COVID-19 vaccine-associated symptoms
Mar 20, 2023
An increased likelihood of experiencing a prolonged neutralizing antibody response was seen for those with vaccine-associated symptoms and prior SARS-CoV-2 infection.
Cardiac complications up after SARS-CoV-2 infection versus vaccines
Apr 06, 2022
“[T]he risks for these complications were higher after infection than after vaccination among males and females in all age groups,” the authors write.